Quick Answer
MoonLake Immunotherapeutics reported Shares Outstanding of 52.70 million shares for fiscal year 2022.
MoonLake Immunotherapeutics Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2022 | 52.70M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | 52.70M | — | — |
- The most recent figure is from MoonLake Immunotherapeutics’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 26, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: